Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EYE National Vision	$25.09	$21.87	$9.56 ▼ $25.52	$1.98B	1.27	1.91 million shs	1.83 million shs
LIVN LivaNova	$41.98 -1.3%	$44.77	$32.48 ▼ $57.35	$2.32B	0.9	628,370 shs	514,249 shs
SMLR Semler Scientific	$41.24 -5.4%	$38.38	$21.77 ▼ $81.56	$596.81M	1.39	579,377 shs	622,725 shs
WRBY Warby Parker	$23.92 +2.0%	$21.23	$12.46 ▼ $28.68	$2.45B	2.09	2.01 million shs	1.62 million shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EYE National Vision	0.00%	+2.58%	+9.09%	+115.00%	+77.06%
LIVN LivaNova	-1.32%	-5.30%	-7.06%	+17.99%	-22.85%
SMLR Semler Scientific	-5.41%	-9.42%	+29.12%	+26.93%	+13.89%
WRBY Warby Parker	+1.99%	+7.75%	+12.11%	+67.85%	+44.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EYE National Vision	2.9311 of 5 stars	2.3	2.0	3.3	3.5	0.8	0.0
LIVN LivaNova	3.3381 of 5 stars	3.5	4.0	0.0	2.4	1.7	1.3
SMLR Semler Scientific	2.6347 of 5 stars	3.7	2.0	0.0	3.0	2.5	0.0
WRBY Warby Parker	2.6088 of 5 stars	2.3	5.0	0.0	2.0	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EYE National Vision	2.56	Moderate Buy	$22.10	-11.92% Downside
LIVN LivaNova	3.00	Buy	$59.29	41.22% Upside
SMLR Semler Scientific	3.33	Buy	$89.00	115.81% Upside
WRBY Warby Parker	2.53	Moderate Buy	$22.88	-4.37% Downside

Current Analyst Ratings Breakdown

Latest SMLR, WRBY, LIVN, and EYE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/10/2025	WRBY Warby Parker	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Perform
7/10/2025	WRBY Warby Parker	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/9/2025	SMLR Semler Scientific	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$95.00
7/8/2025	EYE National Vision	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00
7/8/2025	EYE National Vision	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$30.00
7/8/2025	EYE National Vision	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$17.00 ➝ $30.00
7/8/2025	SMLR Semler Scientific	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$101.00
6/18/2025	EYE National Vision	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$22.00 ➝ $26.00
5/29/2025	WRBY Warby Parker	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00 ➝ $25.00
5/22/2025	WRBY Warby Parker	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$18.00 ➝ $21.00
5/21/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EYE National Vision	$1.85B	1.07	$1.64 per share	15.34	$10.37 per share	2.42
LIVN LivaNova	$1.25B	1.83	$4.19 per share	10.03	$24.31 per share	1.73
SMLR Semler Scientific	$56.29M	10.03	$4.23 per share	9.74	$24.90 per share	1.66
WRBY Warby Parker	$771.32M	3.24	$0.35 per share	69.07	$3.35 per share	7.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EYE National Vision	-$28.50M	-$0.33	N/A	92.93	3.68	-1.40%	3.44%	1.40%	8/6/2025 (Estimated)
LIVN LivaNova	$63.23M	-$4.09	N/A	13.37	N/A	-17.41%	13.67%	6.68%	8/6/2025 (Estimated)
SMLR Semler Scientific	$40.90M	-$2.61	N/A	∞	N/A	-60.69%	19.75%	15.47%	8/4/2025 (Estimated)
WRBY Warby Parker	-$20.39M	-$0.12	N/A	239.20	N/A	-1.79%	-2.48%	-1.29%	8/7/2025 (Confirmed)

Latest SMLR, WRBY, LIVN, and EYE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	WRBY Warby Parker	$0.09	N/A	N/A	N/A	$212.42 million	N/A
8/6/2025	Q2 2025	EYE National Vision	$0.12	N/A	N/A	N/A	$469.21 million	N/A
8/6/2025	Q2 2025	LIVN LivaNova	$0.84	N/A	N/A	N/A	$332.20 million	N/A
5/13/2025	Q1 2025	SMLR Semler Scientific	N/A	-$0.76	N/A	-$6.74	N/A	$8.84 million
5/7/2025	Q1 2025	EYE National Vision	$0.32	$0.34	+$0.02	$0.18	$510.30 million	$510.32 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EYE National Vision	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EYE National Vision	0.29	0.54	0.35
LIVN LivaNova	0.53	1.58	1.37
SMLR Semler Scientific	0.59	0.52	0.51
WRBY Warby Parker	N/A	2.70	2.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EYE National Vision	N/A
LIVN LivaNova	97.64%
SMLR Semler Scientific	49.37%
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
EYE National Vision	2.70%
LIVN LivaNova	0.29%
SMLR Semler Scientific	30.20%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EYE National Vision	13,411	79.05 million	76.92 million	Optionable
LIVN LivaNova	2,900	54.53 million	54.37 million	Optionable
SMLR Semler Scientific	120	13.69 million	9.55 million	Not Optionable
WRBY Warby Parker	3,780	104.50 million	85.44 million	Optionable

SMLR, WRBY, LIVN, and EYE Headlines

Recent News About These Companies

Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025

July 17 at 4:05 PM | businesswire.com

CenterBook Partners LP Invests $1.42 Million in Warby Parker Inc. (NYSE:WRBY)

July 17 at 9:54 AM | marketbeat.com

Head to Head Comparison: Warby Parker (WRBY) & Its Rivals

July 17 at 4:03 AM | americanbankingnews.com

Warby Parker Inc. (NYSE:WRBY) Shares Bought by Bank of New York Mellon Corp

July 16 at 3:39 AM | marketbeat.com

Warby Parker (NYSE:WRBY) Stock Price Up 5.9% - Here's Why

July 14, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Shares Sold by TimesSquare Capital Management LLC

July 14, 2025 | marketbeat.com

Contrasting Warby Parker (WRBY) & The Competition

July 14, 2025 | americanbankingnews.com

Warby Parker (NYSE:WRBY) Cut to Market Perform at Citizens Jmp

July 13, 2025 | americanbankingnews.com

Warby Parker's (WRBY) Market Perform Rating Reiterated at JMP Securities

July 13, 2025 | americanbankingnews.com

JMP Securities Downgrades Warby Parker (WRBY)

July 11, 2025 | msn.com

Warby Parker (NYSE:WRBY) Receives "Market Perform" Rating from JMP Securities

July 10, 2025 | marketbeat.com

Warby Parker (NYSE:WRBY) Stock Rating Lowered by Citizens Jmp

July 10, 2025 | marketbeat.com

Warby Parker Inc. Stock Grades | WRBY - Barron's

July 10, 2025 | barrons.com

Warby Parker Inc. (NYSE:WRBY) Receives $22.88 Average PT from Analysts

July 9, 2025 | americanbankingnews.com

Winners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks

July 8, 2025 | msn.com

Warby Parker Inc. (NYSE:WRBY) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 6, 2025 | marketbeat.com

11,751 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by Diversified Trust Co

July 2, 2025 | marketbeat.com

What Makes Warby Parker (WRBY) an Attractive Investment?

June 30, 2025 | finance.yahoo.com

Bessemer Group Inc. Has $1.17 Million Stock Position in Warby Parker Inc. (NYSE:WRBY)

June 30, 2025 | marketbeat.com

WRBY - Warby Parker Inc Ordinary Shares - Class A Chart - Morningstar

June 28, 2025 | morningstar.comM

The 5 Most Interesting Analyst Questions From Warby Parker’s Q1 Earnings Call

June 27, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, WRBY, LIVN, and EYE Company Descriptions

National Vision NASDAQ:EYE

$25.09 0.00 (0.00%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$24.70 -0.39 (-1.53%)

As of 07/18/2025 05:03 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

LivaNova NASDAQ:LIVN

$41.98 -0.56 (-1.32%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$41.60 -0.38 (-0.90%)

As of 07/18/2025 05:44 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Semler Scientific NASDAQ:SMLR

$41.24 -2.36 (-5.41%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$41.32 +0.08 (+0.19%)

As of 07/18/2025 07:50 PM Eastern

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Warby Parker NYSE:WRBY

$23.92 +0.47 (+2.00%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$23.92 +0.00 (+0.02%)

As of 07/18/2025 05:20 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time